Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection

References

• BouvierNMPalesePThe biology of influenza virusesVaccine200826Suppl 4D49D5319230160
   PubMed Web of Science ®Google Scholar
• DouDRevolRÖstbyeHWangHDanielsRInfluenza A virus cell entry, replication, virion assembly and movementFront Immunol20189158130079062
   PubMed Web of Science ®Google Scholar
• DaviesWLGrunertRRHaffRFAntiviral activity of 1-adamantanamine (amantadine)Science1964144362086286314151624
   PubMedGoogle Scholar
• DongGPengCLuoJAdamantane-resistant influenza a viruses in the world (1902–2013): frequency and distribution of M2 gene mutationsPLoS One2015103e011911525768797
   PubMed Web of Science ®Google Scholar
• YenHLCurrent and novel antiviral strategies for influenza infectionCurr Opin Virol20161812613427344481
   PubMed Web of Science ®Google Scholar
• CohenMZhangXQSenaatiHPInfluenza A penetrates host mucus by cleaving sialic acids with neuraminidaseVirol J20131032124261589
   PubMed Web of Science ®Google Scholar
• HurtACThe epidemiology and spread of drug resistant human influenza virusesCurr Opin Virol20148222924866471
   PubMed Web of Science ®Google Scholar
• KönigRStertzSZhouYHuman host factors required for influenza virus replicationNature2010463728281381720027183
   PubMed Web of Science ®Google Scholar
• HanJPerezJTChenCGenome-wide CRISPR/Cas9 screen identifies host factors essential for influenza virus replicationCell Rep201823259660729642015
   PubMed Web of Science ®Google Scholar
• HaoLSakuraiAWatanabeTDrosophila RNAi screen identifies host genes important for influenza virus replicationNature2008454720689089318615016
   PubMed Web of Science ®Google Scholar
• BaillieJKDigardPInfluenza – time to target the host?N Engl J Med2013369219119323841736
   PubMed Web of Science ®Google Scholar
• HussMWieczorekHInhibitors of V-ATPases: old and new playersJ Exp Biol2009212Pt 334134619151208
   PubMed Web of Science ®Google Scholar
• PiersonTCDiamondMSDegrees of maturity: the complex structure and biology of flavivirusesCurr Opin Virol20122216817522445964
   PubMed Web of Science ®Google Scholar
• TownsleyACWeisbergASWagenaarTRMossBVaccinia virus entry into cells via a low-pH-dependent endosomal pathwayJ Virol200680188899890816940502
   PubMed Web of Science ®Google Scholar
• AlbertiniAABaqueroEFerlinAGaudinYMolecular and cellular aspects of rhabdovirus entryViruses20124111713922355455
   PubMed Web of Science ®Google Scholar
• BelouzardSMilletJKLicitraBNWhittakerGRMechanisms of coronavirus cell entry mediated by the viral spike proteinViruses2012461011103322816037
   PubMed Web of Science ®Google Scholar
• Gonzalez-DuniaDCubittBde la TorreJCMechanism of Borna disease virus entry into cellsJ Virol19987217837889420287
   PubMed Web of Science ®Google Scholar
• BowmanEJSiebersAAltendorfKBafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cellsProc Natl Acad Sci U S A19888521797279762973058
   PubMed Web of Science ®Google Scholar
• OchiaiHSakaiSHirabayashiTShimizuYTerasawaKInhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cellsAntiviral Res19952744254308540761
   PubMed Web of Science ®Google Scholar
• MüllerKHKainovDEEl BakkouriKThe proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infectionsBr J Pharmacol2011164234435721418188
   PubMed Web of Science ®Google Scholar
• YeganehBGhavamiSKroekerALSuppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1Am J Physiol Lung Cell Mol Physiol20153083L270L28625361566
   PubMed Web of Science ®Google Scholar
• ChenHWChengJXLiuMTInhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza virusesAntiviral Res201399337138223820269
   PubMed Web of Science ®Google Scholar
• HuCJChangWSFangZSNanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirusSci Rep2017711304329026122
   PubMedGoogle Scholar
• MakadiaHKSiegelSJPoly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrierPolymers (Basel)2011331377139722577513
   PubMed Web of Science ®Google Scholar
• HrkachJVon HoffDMukkaram AliMPreclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profileSci Transl Med20124128128ra39
   PubMed Web of Science ®Google Scholar
• RobertsRAShenTAllenICHasanWDeSimoneJMTingJPAnalysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particlesPLoS One201384e6211523593509
   PubMed Web of Science ®Google Scholar
• ReedLJMuenchHA simple method of estimating fifty percent endpointsAm J Epidemiol1938273493497
   Google Scholar
• WardCLDempseyMHRingCJDesign and performance testing of quantitative real time PCR assays for influenza A and B viral load measurementJ Clin Virol200429317918814962787
   PubMed Web of Science ®Google Scholar
• BimboLMDenisovaOVMäkiläEInhibition of influenza A virus infection in vitro by saliphenylhalamide-loaded porous silicon nanoparticlesACS Nano2013786884689323889734
   PubMed Web of Science ®Google Scholar
• HuCMFangRHLukBTZhangLPolymeric nanotherapeutics: clinical development and advances in stealth functionalization strategiesNanoscale201461657524280870
   PubMed Web of Science ®Google Scholar
• SillmanBBadeANDashPKCreation of a long-acting nano-formulated dolutegravirNat Commun20189144329402886
   PubMedGoogle Scholar
• PoweJRCastlemanWLCanine influenza virus replicates in alveolar macrophages and induces TNF-alphaVet Pathol20094661187119619605916
   PubMed Web of Science ®Google Scholar
• RodgersBCMimsCAInfluenza virus replication in human alveolar macrophagesJ Med Virol1982931771847097255
   PubMed Web of Science ®Google Scholar
• HeWChenCJMullarkeyCEAlveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in miceNat Commun20178184629018261
   PubMedGoogle Scholar
• GhoneimHEThomasPGMcCullersJADepletion of alveolar macrophages during influenza infection facilitates bacterial superinfectionsJ Immunol201319131250125923804714
   PubMed Web of Science ®Google Scholar
• MbawuikeINHerscowitzHBMH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristicsJ Leukoc Biol19894621191272787372
   PubMed Web of Science ®Google Scholar
• ZhangRAiXDuanYKaempferol ameliorates H9N2 swine influenza virus-induced acute lung injury by inactivation of TLR4/MyD88-mediated NF-κB and MAPK signaling pathwaysBiomed Pharmacother20178966067228262619
   PubMed Web of Science ®Google Scholar
• WuNHYangWBeinekeAThe differentiated airway epithelium infected by influenza viruses maintains the barrier function despite a dramatic loss of ciliated cellsSci Rep201663966828004801
   PubMed Web of Science ®Google Scholar
• ChanRWKangSSYenHLTissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctivaJ Virol20118522115811158721880750
   PubMed Web of Science ®Google Scholar
• MichaelisMGeilerJKlassertDDoerrHWCinatlJJrInfection of human retinal pigment epithelial cells with influenza A virusesInvest Ophthalmol Vis Sci200950115419542519553611
   PubMed Web of Science ®Google Scholar
• CreagerHMKumarAZengHMainesTRTumpeyTMBelserJAInfection and replication of influenza virus at the ocular surfaceJ Virol2018927pii: e02192-17
   Web of Science ®Google Scholar
• BelserJALashRRGargSTumpeyTMMainesTRThe eyes have it: influenza virus infection beyond the respiratory tractLancet Infect Dis2018187e220e22729477464
   PubMed Web of Science ®Google Scholar
• LennyBJShanmuganathamKSonnbergSReplication capacity of avian influenza A(H9N2) virus in pet birds and mammals, BangladeshEmerg Infect Dis201521122174217726583371
   PubMed Web of Science ®Google Scholar
• LudwigSDisruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infectionsBiol Chem20113921083784721823902
   PubMed Web of Science ®Google Scholar
• KoszalkaPTilmanisDHurtACInfluenza antivirals currently in late-phase clinical trialInfluenza Other Respir Viruses201711324024628146320
   PubMed Web of Science ®Google Scholar
• LinLCChattopadhyaySLinJCHuCJAdvances and opportunities in nanoparticle- and nanomaterial-based vaccines against bacterial infectionsAdv Healthc Mater2018713e170139529508547
   PubMed Web of Science ®Google Scholar
• ChattopadhyaySChenJYChenHWHuCJNanoparticle vaccines adopting virus-like features for enhanced immune potentiationNanotheranostics20171324426029071191
   PubMedGoogle Scholar
• NguyenJTSmeeDFBarnardDLEfficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A virusesPLoS One201271e3100622292088
   PubMed Web of Science ®Google Scholar
• HaasbachEHartmayerCPlanzOCombination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitroAntiviral Res201398231932423523553
   PubMed Web of Science ®Google Scholar
• BelardoGCenciarelliOLa FraziaSRossignolJFSantoroMGSynergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitroAntimicrob Agents Chemother20155921061106925451059
   PubMed Web of Science ®Google Scholar
• DunningJBaillieJKCaoBHaydenFGInternational Severe Acute Respiratory and Emerging Infection Consortium (ISARIC)Antiviral combinations for severe influenzaLancet Infect Dis201414121259127025213733
   PubMed Web of Science ®Google Scholar
• MoritaMKubaKIchikawaAThe lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenzaCell2013153111212523477864
   PubMed Web of Science ®Google Scholar
• HuCMZhangLNanoparticle-based combination therapy toward overcoming drug resistance in cancerBiochem Pharmacol20128381104111122285912
   PubMed Web of Science ®Google Scholar
• ChenHWFangZSChenYTTargeting and enrichment of viral pathogen by cell membrane cloaked magnetic nanoparticles for enhanced detectionACS Appl Mater Interfaces2017946399533996129088538
   PubMed Web of Science ®Google Scholar